Clinical trials: Dysglycemia
Spinal Cord Injuries, Obesity
Effects of Intermittent Hypoxia (IH) on Metabolism and Dysglycemia, in Overweight/Obese Persons SCI
The purpose of this research is to examine changes in blood glucose control and metabolism in individuals with SCI and non injured controls at rest and during exercise after five days of exposure to IH.
- Conditions
- Spinal Cord Injuries, Obesity, Insulin Resistance
- Trial name
- NCT02973438
- Testing
- Intermittent Hypoxia (IH)
- Where
- United States
- Volunteers
- 6 people, healthy volunteers welcome
- Sponsor
- University of Miami
Diabetes Mellitus
Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility
This single-arm stepwise feasibility study will test initial deployment of hybrid closed-loop (HCL) automated insulin delivery (AID) using the Omnipod 5/Horizon HCL system with remote monitoring and device operation capabilities…
- Trial name
- NCT04714216
- Testing
- The Omnipod 5/Horizon HCL system
- Where
- 3 sites in United States
- Volunteers
- 22 people
- Sponsor
- Emory University
Obesity, Dysglycemia
Metabolic Effects of Betaine Supplementation
Betaine is important in cellular metabolic pathways. Few epidemiologic studies link betaine levels to diabetes and cardiovascular disease. Small human studies suggest benefit for non-alcoholic liver disease.
- Trial name
- NCT01950039
- Testing
- Betaine
- Where
- United States
- Volunteers
- 28 people
- Sponsor
- Joslin Diabetes Center
Gestational Diabetes
Postpartum Continuous Glucose Monitoring (CGM) Study
This research study is being done to assess if using a glucose sensor (also known as a continuous glucose monitor) after childbirth can help identify women who are at risk of developing diabetes after having diabetes during…
- Trial name
- NCT05714761
- Testing
- Dexcom glucose sensor
- Where
- United States
- Volunteers
- 50 people
- Sponsor
- Icahn School of Medicine at Mount Sinai
ICU, Dysglycemia
Glucose Time-In-Range Development Evaluation
The study will evaluate patients requiring frequent glucose monitoring in a Surgical ICU. The study population includes surgical critical care patients who require blood glucose monitoring.
- Trial name
- GIDE (NCT03670017)
- Testing
- OptiScanner® 5000 Glucose Monitoring System
- Where
- United States
- Volunteers
- 68 people
- Sponsor
- Washington University School of Medicine